U.S. Markets closed

Immunomedics (IMMU) Jumps: Stock Adds 10.3% in Session

Zacks Equity Research

Immunomedics Inc. (IMMU) was a big mover last session, as the company saw its shares rise over 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the uptrend for the company since Dec 11, as the stock is now up over 19%.

This biopharmaceutical company has seen no estimate revision in the last 30 days and the Zacks Consensus Estimate has also remained unchanged. Tuesday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Immunomedics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Better-ranked stocks in the same industry include GeoVax Labs, Inc. (GOVX), Vanda Pharmaceuticals, Inc. (VNDA) and Heska Corp. (HSKA). All these stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

IMMUNOMEDICS INC (IMMU): Free Stock Analysis Report

GEOVAX LABS INC (GOVX): Free Stock Analysis Report


HESKA CORP (HSKA): Free Stock Analysis Report

Zacks Investment Research